Ndzhentiks Overview

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $424K

  • Investors
  • 1

Ndzhentiks General Information


Developer of drugs for tuberculosis. The company develops drugs using a molecular-genetic platform for treating drug-resistant tuberculosis through semiconductor sequencing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • ul. Aviakonstruktora Mikoyana, 12
  • Room 1
  • Moscow, 125252
  • Russia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ndzhentiks Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 02-Dec-2014 $424K 00000 Completed Startup
1. Angel (individual) 02-Dec-2014 00000 00000 Completed Startup
To view Ndzhentiks’s complete valuation and funding history, request access »

Ndzhentiks Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Skolkovo Foundation Limited Partner 000 0000 000000 0
To view Ndzhentiks’s complete investors history, request access »